News
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Novo Nordisk partners with telehealth ...
With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
6d
inews.co.uk on MSN1.5m Britons a month pay for weight-loss jabs - and pharmacies 'ready' to step upHigh-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans.
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results